105798-74-1
105798-74-1 结构式
基本信息
中文别名
克力托辛 英文别名
clitocineN-(6-Amino-5-nitro-4-pyrimidinyl)-β-D-ribofuranosylamine
b-D-RibofuranosylaMine, N-(6-aMino-5-nitro-4-pyriMidinyl)-
N-(6-Amino-5-nitro-4-pyrimidinyl)-beta-D-ribofuranosylamine
β-D-Ribofuranosylamine, N-(6-amino-5-nitro-4- pyrimidinyl)-
克力托辛价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2025/12/22 | HY-118341 | 克力托辛 Clitocine | 105798-74-1 | 1 mg | 1818元 |
| 2025/12/22 | HY-118341 | 克力托辛 Clitocine | 105798-74-1 | 5mg | 4000元 |
| 2025/12/22 | HY-118341 | 克力托辛 Clitocine | 105798-74-1 | 10mM * 1mLin DMSO | 4400元 |
常见问题列表
生物活性
Clitocine 是一种来源于蘑菇的腺苷核苷类似物，是一种有效的通读剂 (readthrough)。Clitocine 作为一种无义突变 (nonsense mutations) 的抑制剂，可诱导携带 p53 无义突变等位基因的细胞产生 p53 蛋白。Clitocine 可通过靶向 Mcl-1 诱导多药耐药肿瘤细胞凋亡。具有抗癌活性。体外研究
Clitocine incorporation into mRNA is required for premature stop codon readthrough activity, and the presence of clitocine at the third position of a premature stop codon is sufficient to promote robust readthrough.
Clitocine (0-0.8 μM; 24 hours) enhances TRAIL-lethality in in LS411N and SW620 cells. Clitocine (0.2μM; 36 hours) significantly potentiates TRAIL-mediated apoptosis.
体内研究
Citocine (0.3-3 mg/kg; s.c.; five times per week)-induced p53 inhibits CAOV-33 p53-UAA136 tumor growth in a xenograft model.
| Animal Model: | nu/nu mice (CAOV-3p53-UAA136 xenograft tumors) |
| Dosage: | 0.3, 3 mg/kg (or 20 mg/kg once per week) |
| Administration: | S.c.; five times per week |
| Result: | CAOV-33 p53-UAA136 tumor growth was inhibited. |